E-drug: phenylpropanolamine (cont)
---------------------------------------------
Sjukehusapoteket Elverum <sjappe@apotek.no> writes
The Pharmaceutical Journal (Vol 265 11. November 2000) has an
interesting article about the difference in the isomeric forms of
phenylpropanolamine used in Europe and US.
There appears to have been an error, the editor of the Martindale has
written to the Journal to point this out:
Quote:In The Pharmaceutical Journal of November 11 the article on
phenylpropanolamine correctly reported the information given to you by
one of us (Professor Moffat) and contained in Martindale. Since then,
we have been checking the original sources of that information and have
found a number of inaccuracies. We now wish to put the record straight.
The important fact to note is that the drug named phenylpropanolamine is
the same in the United States as it is in Europe.
Full explanation at:
http://www.pharmj.com/Editorial/20001202/letters/Moffat.html
All the best
--
Anthony Cox ADR Pharmacist
West Midlands Centre for Adverse Drug Reaction Reporting
City Hospital NHS Trust, Dudley Road, Birmingham, B18 7QH. UK.
http://www.csmwm.org
Anthony Cox <RX@blacktriangle.org>
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.